Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 1066 AL 1080

Exploring the efficacy and safety of lecanemab in the management of early Alzheimer's disease: A systematic review of clinical evidence

Ashmawy RE, Okesanya OJ, Ukoaka BM, Daniel FM, Ezedigwe SG, Agboola AO, Ahmed MM, Ogaya JB, Amisu BO, Adigun OA, Oluwakemi OG, Hamza AM, Mourid MR, Kouwenhoven M, Lucero-Prisno DE 3rd.

J Alzheimers Dis. 2025 Jun;105(3):714-728. doi: 10.1177/13872877251331640. Epub 2025 Apr 15.

Artificial intelligence-driven eye tracker models for Alzheimer's disease diagnosis: A systematic review and meta-analysis

Ketata I, Ellouz E.

J Alzheimers Dis. 2025 Dec;108(4):1488-1506. doi: 10.1177/13872877251389145. Epub 2025 Oct 24.

Efficacy and APOE ε4-stratified risk of donanemab in Alzheimer's disease: A systematic review and meta-analysis of randomized clinical trials

Pereira da Silva AM, Falcão L, Virgilio F, Rodrigues Menezes I, Leite M, Farias E, Nascimento M, Lee Han M, Mota Telles JP, de Souza Franco E, de Sousa Maia MB.

J Alzheimers Dis. 2025 Sep;107(2):477-493. doi: 10.1177/13872877251361044. Epub 2025 Sep 1.

Multi Layered Omics Approaches Reveal Glia Specific Alterations in Alzheimer's Disease: A Systematic Review and Future Prospects

İş Ö, Min Y, Wang X, Oatman SR, Abraham Daniel A, Ertekin-Taner N.

Glia. 2025 Mar;73(3):539-573. doi: 10.1002/glia.24652. Epub 2024 Dec 9.

Effectiveness of virtual reality interventions on quality of life, cognitive function and physical function in older people with Alzheimer's disease: A systematic review

Vásquez-Carrasco E, Hernandez-Martinez J, Sepúlveda-Ramírez M, Carmine F, Sandoval C, Nobari H, Valdés-Badilla P.

Ageing Res Rev. 2025 Jul;109:102785. doi: 10.1016/j.arr.2025.102785. Epub 2025 May 26.

Artificial Intelligence for Alzheimer's disease diagnosis through T1-weighted MRI: A systematic review

Basanta-Torres S, Rivas-Fernández MÁ, Galdo-Alvarez S.

Comput Biol Med. 2025 Oct;197(Pt A):111028. doi: 10.1016/j.compbiomed.2025.111028. Epub 2025 Sep 5.

Alzheimer's Disease and Circulatory Imbalance of Toxic Heavy Metals: A Systematic Review and Meta-analysis of Clinical Studies

Kooshki A, Farmani R, Mehrpour O, Naghizadeh A, Amirabadizadeh A, Kavoosi S, Vohra V, Nakhaee S.

Biol Trace Elem Res. 2025 Apr;203(4):1871-1885. doi: 10.1007/s12011-024-04326-x. Epub 2024 Jul 30.

Therapeutic potential of traditional chinese medicine polysaccharides in alzheimer's disease via modulation of gut microbiota: A review

Wang T, Gao C, Dong X, Li L.

Int J Biol Macromol. 2025 Sep;321(Pt 2):146160. doi: 10.1016/j.ijbiomac.2025.146160. Epub 2025 Jul 18.

Natural Evolution and Heterogeneity of Neuropsychiatric Symptoms Across Neurocognitive Disorders: A Systematic Review and Meta-Analysis of Longitudinal Studies

Skoda O, Conant M, Couture V, Bruneau MA, Forget MF, Nguyen QD, Desmarais P.

Int J Geriatr Psychiatry. 2025 Oct;40(10):e70169. doi: 10.1002/gps.70169.

Lower baseline amyloid beta burden is associated with greater percent of amyloid beta positron emission tomography reduction and better clinical outcomes in the aducanumab Phase 3 trials ENGAGE and EMERGE in early Alzheimer's disease

Burton J, Brothers HM, Hutchison RM, Murphy J, Sun T, Dent G, Curiale G, Kowalski K.

J Prev Alzheimers Dis. 2025 Aug;12(7):100202. doi: 10.1016/j.tjpad.2025.100202. Epub 2025 May 24.

Mobile Telehealth Intervention to Support Care Partners of Patients With Alzheimer Disease and Related Dementias (I-CARE 2): Protocol for a Randomized Effectiveness Clinical Trial

Hill JR, Gardner B, Rodriguez MJ, Golzarri-Arroyo L, Zoh RS, Boustani Z, Burnell J, Jordan EJ, Boustani MA, Holden RJ.

JMIR Res Protoc. 2025 Sep 3;14:e73387. doi: 10.2196/73387.

Hypometabolic subtypes of AD are linked to comorbid hippocampal sclerosis and Lewy body pathology

Levin F, Dyrba M, Teipel SJ, Grothe MJ.

Alzheimers Res Ther. 2025 Jul 25;17(1):172. doi: 10.1186/s13195-025-01796-6.

Fornix Mediates Information Propagation in Brain Networks Following DLPFC-Targeted rTMS in Alzheimer's Disease: A Randomized Controlled Trial

Shao Y, Liu L, Zhu S, Zhu Z, Wang P, Biswal BB, Lin H.

CNS Neurosci Ther. 2025 Nov;31(11):e70630. doi: 10.1111/cns.70630.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias